Dynamic Respiratory Muscle Strength and Endurance in Childhood Asthma
NCT ID: NCT06053905
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-03-13
2024-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinants of Functional Capacity in Children With Asthma
NCT05963919
Evaluation of the Possible Effect of Inspiratory Muscle Training on Inflammation Markers and Oxidative Stress in Childhood Asthma
NCT05296707
Development of an Active Video-Based High-Intensity Interval Exercise System in Children With Asthma
NCT06895642
Investigation of Physical Activity Level, Cardiorespiratory Fitness and Quality of Life in Patients With Asthma
NCT03509311
Aerobic Exercise in Children With Moderate and Severe Asthma
NCT01920529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthmatic Child
Children with asthma between 6-11 years old
No interventions assigned to this group
Healthy Controls Group
Healthy children between 6-11 years old
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those who have been diagnosed with asthma,
* Clinically stable and not in active asthma attack,
* Between the ages of 6-11,
* Giving consent on a voluntary basis,
* cooperative,
* Not having any chronic disease for healthy individuals,
* be between the ages of 6-11,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,
Exclusion Criteria
* Having serious diseases such as cancers, heart failure and acute respiratory infections,
* Having chronic lung disease other than asthma,
* Severe neuromuscular and musculoskeletal problems,
* Uncooperative to do the tests,
* For safety reasons, patients admitted or hospitalized in the last 3 months due to an asthma attack will not be included in the study.
* The presence of a medical indication that requires complete restriction of physical activity,
* Having symptoms of any chronic or acute illness involving the lungs
* Existence of cooperation and communication problems
6 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Bartın Unıversity
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şeyma Nur Önal
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ebru Calik Kutukcu, PhD
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ebru Çalik Kütükcü
Ankara, Altındağ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO23/241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.